Commerzbank AG (OTCMKTS:CRZBY – Get Free Report) was the target of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 15,400 shares, a decline of 11.0% from the May 31st total of 17,300 shares. Based on an average daily volume of 18,200 shares, the short-interest ratio is currently 0.8 days.
Commerzbank Price Performance
CRZBY opened at $15.66 on Wednesday. Commerzbank has a 1 year low of $9.72 and a 1 year high of $17.09. The company has a debt-to-equity ratio of 14.86, a current ratio of 32.55 and a quick ratio of 32.55. The company has a market capitalization of $19.42 billion, a price-to-earnings ratio of 8.07 and a beta of 1.02. The firm’s fifty day moving average price is $15.79 and its two-hundred day moving average price is $13.64.
Commerzbank (OTCMKTS:CRZBY – Get Free Report) last released its quarterly earnings results on Wednesday, May 15th. The financial services provider reported $0.67 earnings per share for the quarter. Commerzbank had a net margin of 10.27% and a return on equity of 6.71%. The company had revenue of $2.98 billion for the quarter. As a group, analysts anticipate that Commerzbank will post 2.05 earnings per share for the current fiscal year.
Commerzbank Increases Dividend
Wall Street Analyst Weigh In
Separately, Citigroup downgraded Commerzbank from a “buy” rating to a “neutral” rating in a research note on Monday, June 3rd.
Check Out Our Latest Stock Analysis on Commerzbank
About Commerzbank
Commerzbank AG provides banking and capital market products and services to private and small business customers, corporate, financial service providers, and institutional clients in Germany, rest of Europe, the Americas, Asia, and internationally. It operates through two segments, Private and Small-Business Customers, and Corporate Clients.
Featured Articles
- Five stocks we like better than Commerzbank
- What is the NASDAQ Stock Exchange?
- RXO Shares Surge Following New Acquisition Deal
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How to Most Effectively Use the MarketBeat Earnings Screener
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Commerzbank Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Commerzbank and related companies with MarketBeat.com's FREE daily email newsletter.